rethinkPeptides Search
Menu
Home / Research library
Study breakdown

Measuring Opioid Peptides in Human Blood: Dynorphin B Is Stable but Dynorphin A Rapidly Degrades

RPEP-004941998Silberring, J; Li, Y M; Terenius, L; Nylander, I
In VitroPreliminary evidence
The takeaway

Dynorphin B and beta-endorphin circulate in human blood at measurable levels, but dynorphin A is rapidly converted to leu-enkephalin, explaining why it's undetectable in plasma.

Rapid degradation

Dynorphin A added to human plasma was rapidly converted to leu-enkephalin, explaining why it is undetectable in blood samples

What the researchers found

Dynorphin B and beta-endorphin were confirmed in human plasma by HPLC and mass spectrometry, while dynorphin A was undetectable due to rapid enzymatic conversion to leu-enkephalin in blood.

Why it matters

Understanding which opioid peptides are stable enough to circulate in blood versus those degraded immediately helps researchers choose the right biomarkers and design more stable peptide therapeutics.

How the study worked

In-vitro analytical study using radioimmunoassay, HPLC, and mass spectrometry to characterize opioid peptides in human plasma. Stability experiments tracked dynorphin A degradation in blood.

What this study cannot tell us

In-vitro characterization study. Blood processing can affect peptide levels. Individual variation in peptide levels was not extensively characterized.

How to read the evidence

Preliminary evidence from a well-designed analytical study with mass spectrometric confirmation, providing reliable characterization data.

When this study was published

Published in 1998. These findings have informed subsequent research on opioid peptide stability and biomarker development.

The bigger picture

The body's opioid system includes many peptides with different stabilities and functions. Knowing that dynorphin A is rapidly degraded in blood while dynorphin B persists suggests they have fundamentally different roles — dynorphin A as a local signal, dynorphin B as a circulating one.

Questions still open

  • What enzymes degrade dynorphin A so rapidly in blood?
  • Could dynorphin B blood levels serve as a biomarker for pain or stress conditions?
  • Can dynorphin A analogs be designed to resist blood degradation?

Common questions

What are dynorphins?
Dynorphins are a family of opioid peptides produced naturally in the brain and body. They primarily activate kappa-opioid receptors and are involved in pain modulation, stress responses, and mood regulation.
Why does it matter that dynorphin A degrades in blood?
If a peptide is destroyed immediately in blood, it can't serve as a circulating signal or blood biomarker. This means dynorphin A works locally in tissues where it's released, while dynorphin B can travel through the bloodstream to affect distant organs.

Read the original research

Characterization of immunoreactive dynorphin B and beta-endorphin in human plasma.

Peptides, 19(8), 1329-37

View on PubMed ↗

Citation

Silberring, J; Li, Y M; Terenius, L; Nylander, I. (1998). Characterization of immunoreactive dynorphin B and beta-endorphin in human plasma.. Peptides, 19(8), 1329-37.